More than 90% of cases of congenital adrenal hyperplasia (CAH, the inherited inability to
synthesize cortisol) are caused by 21-hydroxylase deficiency. Females with severe, classic …

Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder
regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline …

Objective To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase
deficiency clinical practice guideline published by the Endocrine Society in 2010 …

Objective: We developed clinical practice guidelines for congenital adrenal hyperplasia
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …

Congenital adrenal hyperplasia (CAH) caused by 21‐hydroxylase deficiency accounts for
95% of all CAH cases and is one of the most common inborn metabolic conditions. The …

Nonclassic congenital adrenal hyperplasia (NCAH) is one of the most frequent autosomal
recessive disorders in man with a prevalence ranging from 0.1% in Caucasians up to a few …

A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region.
The annual incidence is 0.5–2.0 cases/million/year and approximately 60% of CP are seen …

Context: Patients with primary adrenal insufficiency (PAI) and patients with congenital
adrenal hyperplasia (CAH) receive glucocorticoid replacement therapy, which might cause …

Context: Patients with classical congenital adrenal hyperplasia (CAH) receive lifelong, often
supraphysiological, glucocorticoid therapy. Pharmacological doses of glucocorticoids are an …

Our knowledge of the experience of adults with congenital adrenal hyperplasia (CAH) as
they pass through life is only now emerging. In this review we gather medical, surgical and …